Lung Development Section, Biology of Breathing Group, Manitoba Institute of Child Health & Departments of Oral Biology and Anatomy, Faculties of Dentistry and Medicine, University of Manitoba, Winnipeg, Canada
Cigarette smoking, one of the most pervasive habits in society, presents many well established health risks. While lung cancer is probably the most common and well documented disease associated with tobacco exposure, it is becoming clear from recent research that many other diseases are causally related to smoking. Whether from direct smoking or inhaling environmental tobacco smoke (ETS), termed secondhand smoke, the cells of the respiratory tissues and the lining pulmonary surfactant are the first body tissues to be directly exposed to the many thousands of toxic chemicals in tobacco. Considering the vast surface area of the lung and the extreme attenuation of the blood-air barrier, it is not surprising that this organ is the primary route for exposure, not just to smoke but to most environmental contaminants. Recent research has shown that the pulmonary surfactant, a complex mixture of phospholipids and proteins, is the first site of defense against particulates or gas components of smoke. However, it is not clear what effect smoke has on the surfactant. Most studies have demonstrated that smoking reduces bronchoalveolar lavage phospholipid levels. Some components of smoke also appear to have a direct detergent-like effect on the surfactant while others appear to alter cycling or secretion. Ultimately these effects are reflected in changes in the dynamics of the surfactant system and, clinically in changes in lung mechanics. Similarly, exposure of the developing fetal lung through maternal smoking results in postnatal alterations in lung mechanics and higher incidents of wheezing and coughing. Direct exposure of developing lung to nicotine induces changes suggestive of fetal stress. Furthermore, identification of nicotinic receptors in fetal lung airways and corresponding increases in airway connective tissue support a possible involvement of nicotine in postnatal asthma development. Finally, at the level of the alveoli of the lung, colocalization of nicotinic receptors and surfactant-specific protein in alveolar cells is suggestive of a role in surfactant metabolism. Further research is needed to determine the mechanistic effects of smoke and its components on surfactant function and, importantly, the effects of smoke components on the developing pulmonary system.
REFERENCES(246)
1.
Goodman J: Webs of drug dependence: Towards a political history of Tobacco. Ashes to Ashes: The History of Smoking and Health. Edited by: Lock S, Reynolds LA, Tansey EM. 1995, Rodopi B.V. Amsterdam, 5-39.
Doll R: The first reports on smoking and lung cancer. Ashes to Ashes: The History of Smoking and Health. Edited by: Lock S, Reynolds LA, Tansey EM. 1995, Rodopi B.V. Amsterdam, 130-140.
Anthony HM: Reactive changes in the blood of smokers and the development of arterial diseases and COPD, a review: evidence of associations between changes and subsequent disease with implications for the evaluation of harmful effects of cigarettes, and for susceptibility to the chronic effects of inhaled pollutants. Rev Environ Health. 1989, 8: 25-86.
Coxson HO, Rogers RM, Whittall KP, D'Yachkova Y, Pare PD, Sciurba FC, Hogg JC: A quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med. 1999, 159: 851-856.
McCrae K, Shaw A, Mantsch HH, Thliveris JA, Das RM, Ahmed MK, Scott JE: Lung cancer. Occurrence and new possibilities for detection. International Journal of Health Care Quality Assurance. 1999, 12: I-XIII.
Coxson HO, Hogg JC: Erratum: a quantification of the lung surface area in emphysema using computed tomography. Am J Respir Crit Care Med. 2001, 163: 1500-1501.
Sorokin S: The cells of the lungs. Morphology of Experimental Carcinogesis. Edited by: Nettesheim P, Hana P, Deatherage JW. 1970, CONF 700501, Atomic Energy Commission, Oak Ridge, Tenn, 3-43.
Mason CD, Rand TG, Oulton M, MacDonald JM, Scott JE: Effects of Stachybotrys chartarum (atra) conidia and isolated toxin on lung surfactant production and homeostasis. Nat Toxins. 1998, 6: 27-33.
Akino T: Lipid components of the surfactant system. Pulmonary Surfactant: from molecular biology to clinical practice. Edited by: van Golde LMG, Batenburg JJ. 1992, Elsevier Science Publishers, New York NY, 19-31.
Orgeig S, Daniels CB: The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies. Comp Biochem Physiol A Mol Integr Physiol. 2001, 129: 75-89.
Tolle A, Meier W, Rudiger M, Hofmann KP, Rustow B: Effect of cholesterol and surfactant protein B on the viscosity of phospholipid mixtures. Chem Phys Lipids. 2002, 114: 159-168.
Daniels C, Orgeig S: Understanding the evolution of developmental physiology using cell culture and tissue regeneration models. New Directions in Comparative Developmental Physiology. Edited by: Warburton S. 2004, Oxford University Press.
Langman C, Orgeig S, Daniels CB: Alterations in composition and function of surfactant associated with torpor in Sminthopsis crassicaudata. Am J Physiol. 1996, 271: R437-445.
Daniels CB, Orgeig S, Wood PG, Sullivan LC, Lopatko OV, Smits AV: The changing state of surfactant lipids: New insights from ancient animals. American Zoologist. 1998, 38: 305.
Daniels CB, Barr HA, Power JH, Nicholas TE: Body temperature alters the lipid composition of pulmonary surfactant in the lizard Ctenophorus nuchalis. Exp Lung Res. 1990, 16: 435-449.
King RJ: Pulmonary surface active material: Basic concepts. Mead Johnson Symposium on Perinatal and Developmental Medicine, No. 14. 1978, Mead Johnson & Co. Evansville Indiana, U.S.A. 47721.
Ross M, Krol S, Janshoff A, Galla HJ: Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C. Eur Biophys J. 2002, 31: 52-61.
Amrein M, von Nahmen A, Sieber M: A scanning force- and fluorescence light microscopy study of the structure and function of a model pulmonary surfactant. Eur Biophys J. 1997, 26: 349-357.
Bleasdale JE: Regulation of the lipid composition of lung surfactant. Inositol and phosphoinositides. Metabolism and Regulation. Edited by: Bleasdale JE, Eichberg J, Hauser G. 1985, Humana Press, Clifton, NJ, 13-30.
Kogon DP, Oulton M, Gray JH, Liston RM, Luther ER, Peddle LJ, Young DC: Amniotic fluid phosphatidylglycerol and phosphatidylcholine phosphorus as predictors of fetal lung maturity. Am J Obstet Gynecol. 1986, 154 (2): 226-30.
Ashwood ER: Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem. 1997, 43: 211-214.
DeRoche ME, Ingardia CJ, Guerette PJ, Wu AH, LaSala CA, Mandavilli SR: The use of lamellar body counts to predict fetal lung maturity in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol. 2002, 187: 908-912.
Loret de Mola JR, Judge N, Entsminger C, DeViney M, Muise KL, Duchon MA: Indirect prediction of fetal lung maturity. Value of ultra-sonographic colonic and placental grading. J Reprod Med. 1998, 43: 898-902.
Hallman M, Enhorning G, Possmayer F: Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr Res. 1985, 19: 286-292.
Takamoto DY, Lipp MM, von Nahmen A, Lee KY, Waring AJ, Zasadzinski JA: Interaction of lung surfactant proteins with anionic phospholipids. Biophys J. 2001, 81: 153-169.
Sanders RL: The composition of pulmonary surfactant. Lung Development: Biological and Clinical Perspectives. Edited by: Farrell PM. 1982, Academic Press New York NY, I: 179-210.
Wong CJ, Akiyama J, Allen L, Hawgood S: Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse. Pediatr Res. 1996, 39: 930-937.
McCormack FX, Pattanajitvilai S, Stewart J, Possmayer F, Inchley K, Voelker DR: The Cys6 intermolecular disulfide bond and the collagen-like region of rat SP-A play critical roles in interactions with alveolar type II cells and surfactant lipids. J Biol Chem. 1997, 272: 27971-27979.
Ruano ML, Nag K, Worthman LA, Casals C, Perez-Gil J, Keough KM: Differential partitioning of pulmonary surfactant protein SP-A into regions of monolayers of dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylcholine/dipalmitoylphosphatidylglycerol. Biophys J. 1998, 74: 1101-1109.
Rodriguez-Capote K, McCormack FX, Possmayer F: Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain. J Biol Chem. 2003.
Tsuzuki A, Kuroki Y, Akino T: Pulmonary surfactant protein A-mediated uptake of phosphatidylcholine by alveolar type II cells. Am J Physiol. 1993, 265: L193-199.
Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA: Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA. 1996, 93: 9594-9599.
Williams MC, Hawgood S, Hamilton RL: Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol. 1991, 5: 41-50.
Ikegami M, Korfhagen TR, Whitsett JA, Bruno MD, Wert SE, Wada K, Jobe AH: Characteristics of surfactant from SP-A-deficient mice. Am J Physiol. 1998, 275: L247-254.
Crouch E, Rust K, Persson A, Mariencheck W, Moxley M, Longmore W: Primary translation products of pulmonary surfactant protein D. Am J Physiol. 1991, 260: L247-253.
Hartshorn KL, White MR, Shepherd V, Reid K, Jensenius JC, Crouch EC: Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol. 1997, 273: L1156-1166.
Hartshorn KL, White MR, Voelker DR, Coburn J, Zaner K, Crouch EC: Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J. 2000, 351 (Pt 2): 449-458.
Taneva S, Voelker DR, Keough KM: Adsorption of pulmonary surfactant protein D to phospholipid monolayers at the air-water interface. Biochemistry. 1997, 36: 8173-8179.
Zhang L, Ikegami M, Crouch EC, Korfhagen TR, Whitsett JA: Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J Biol Chem. 2001, 276: 19214-19219.
Ikegami M, Hull WM, Yoshida M, Wert SE, Whitsett JA: SP-D and GM-CSF regulate surfactant homeostasis via distinct mechanisms. Am J Physiol Lung Cell Mol Physiol. 2001, 281: L697-703.
Hawgood S, Benson BJ, Schilling J, Damm D, Clements JA, White RT: Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28–36 in surfactant lipid adsorption. Proc Natl Acad Sci USA. 1987, 84: 66-70.
Andersson M, Curstedt T, Jornvall H, Johansson J: An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 1995, 362: 328-332.
Shanmukh S, Howell P, Baatz JE, Dluhy RA: Effect of hydrophobic surfactant proteins SP-B and SP-C on phospholipid monolayers. Protein structure studied using 2D IR and beta correlation analysis. Biophys J. 2002, 83: 2126-2141.
deMello DE, Heyman S, Phelps DS, Hamvas A, Nogee L, Cole S, Colten HR: Ultrastructure of lung in surfactant protein B deficiency. Am J Respir Cell Mol Biol. 1994, 11: 230-239.
Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA: Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA. 1995, 92: 7794-7798.
Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE, Colten HR: A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest. 1994, 93: 1860-1863.
Pastrana B, Mautone AJ, Mendelsohn R: Fourier transform infrared studies of secondary structure and orientation of pulmonary surfactant SP-C and its effect on the dynamic surface properties of phospholipids. Biochemistry. 1991, 30: 10058-10064.
Creuwels LA, Demel RA, van Golde LM, Benson BJ, Haagsman HP: Effect of acylation on structure and function of surfactant protein C at the air-liquid interface. J Biol Chem. 1993, 268: 26752-26758.
Bi X, Flach CR, Perez-Gil J, Plasencia I, Andreu D, Oliveira E, Mendelsohn R: Secondary structure and lipid interactions of the N-terminal segment of pulmonary surfactant SP-C in Langmuir films: IR reflection-absorption spectroscopy and surface pressure studies. Biochemistry. 2002, 41: 8385-8395.
Flach CR, Gericke A, Keough KM, Mendelsohn R: Palmitoylation of lung surfactant protein SP-C alters surface thermodynamics, but not protein secondary structure or orientation in 1,2-dipalmitoylphosphatidylcholine langmuir films. Biochim Biophys Acta. 1999, 1416: 11-20.
Chevalier G, Collet AJ: In vivo incorporation of choline- 3 H, leucine- 3 H and galactose- 3 H in alveolar type II pneumocytes in relation to surfactant synthesis. A quantitative radoautographic study in mouse by electron microscopy. Anat Rec. 1972, 174: 289-310.
Gobran LI, Rooney SA: Surfactant secretagogue activation of protein kinase C isoforms in cultured rat type II cells. Am-J-Physiol. 1999, 277: L251-256.
Moxley MA, Jacoby J, Longmore WJ: Uptake and reutilization of surfactant phospholipids by type II cells of isolated perfused lung. Am J Physiol. 1991, 260: L268-273.
Scott JE: Phosphatidylcholine synthesis, secretion, and reutilization during differentiation of the surfactant-producing type II alveolar cell from fetal rabbit lungs. Exp Lung Res. 1992, 18: 563-580.
Kresch MJ, Cipriani LA, Lu H, Christian C: Developmental regulation of re-uptake of phosphatidylcholine by type II alveolar epithelium. Bio-chim-Biophys-Acta. 1994, 1210 (2): 167-73.
Gross NJ, Kellam M, Young J, Krishnasamy S, Dhand R: Separation of alveolar surfactant into subtypes. A comparison of methods. Am J Respir Crit Care Med. 2000, 162: 617-622.
Oulton M, Moores HK, Scott JE, Janigan DT, Hajela R: Effects of smoke inhalation on surfactant phospholipids and phospholipase A2 activity in the mouse lung. Am J Pathol. 1991, 138: 195-202.
Pastrana-Rios B, Flach CR, Brauner JW, Mautone AJ, Mendelsohn R: A direct test of the "squeeze-out" hypothesis of lung surfactant function. External reflection FT-IR at the air/water interface. Biochemistry. 1994, 33: 5121-5127.
von Nahmen A, Schenk M, Sieber M, Amrein M: The structure of a model pulmonary surfactant as revealed by scanning force microscopy. Biophys J. 1997, 72: 463-469.
Knebel D, Sieber M, Reichelt R, Galla HJ, Amrein M: Scanning force microscopy at the air-water interface of an air bubble coated with pulmonary surfactant. Biophys J. 2002, 82: 474-480.
Taneva S, Keough KM: Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids. Biophys J. 1994, 66: 1149-1157.
Taneva SG, Keough KM: Dynamic surface properties of pulmonary surfactant proteins SP-B and SP-C and their mixtures with dipalmitoylphosphatidylcholine. Biochemistry. 1994, 33: 14660-14670.
Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P, Brennan P, Darby SC, Forastiere F, Fortes C, Gaborieau V, Gerken M, Gonzales CA, Jockel KH, Kreuzer M, Merletti F, Nyberg F, Pershagen G, Pohlabeln H, Rosch F, Whitley E, Wichmann HE, Zambon P: Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer. 2001, 91: 876-887.
Kreuzer M, Heinrich J, Kreienbrock L, Rosario AS, Gerken M, Wichmann HE: Risk factors for lung cancer among nonsmoking women. Int J Cancer. 2002, 100: 706-713.
Robin M, Dong P, Hermans C, Bernard A, Bersten AD, Doyle IR: Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J. 2002, 20: 1152-1161.
Nikula KJ, Vallyathan V, Green FH, Hahn FF: Influence of exposure concentration or dose on the distribution of particulate material in rat and human lungs. Environ Health Perspect. 2001, 109: 311-318.
Pinkerton KE, Green FH, Saiki C, Vallyathan V, Plopper CG, Gopal V, Hung D, Bahne EB, Lin SS, Menache MG, Schenker MB: Distribution of particulate matter and tissue remodeling in the human lung. Environ Health Perspect. 2000, 108: 1063-1069.
Darquenne C, Paiva M: Two- and three-dimensional simulations of aerosol transport and deposition in alveolar zone of human lung. J Appl Physiol. 1996, 80: 1401-1414.
Churg A, Wright JL, Stevens B: Exogenous mineral particles in the human bronchial mucosa and lung parenchyma. I. Nonsmokers in the general population. Exp Lung Res. 1990, 16: 159-175.
Churg A, Wright JL, Stevens B, Wiggs B: Mineral particles in the human bronchial mucosa and lung parenchyma. II. Cigarette smokers without emphysema. Exp Lung Res. 1992, 18: 687-714.
Gehr P, Green FH, Geiser M, Im Hof V, Lee MM, Schurch S: Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J Aerosol Med. 1996, 9: 163-181.
Banerjee R, Bellare J: Effect of calcium on the surface properties of phospholipid monolayers with respect to surfactant formulations in respiratory distress syndrome. Biomed Mater Eng. 2001, 11: 43-53.
Leanderson P, Tagesson C: Cigarette smoke-induced DNA damage in cultured human lung cells: role of hydroxyl radicals and endonuclease activation. Chem Biol Interact. 1992, 81: 197-208.
Matsumoto K, Aizawa H, Inoue H, Takata S, Shigyo M, Hara N: Role of thromboxane-A2 and cholinergic mechanisms in bronchoconstriction induced by cigarette smoke in guineapigs. Eur Respir J. 1996, 9: 2468-2473.
Low RB, Davis GS, Giancola MS: Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. Am Rev Respir Dis. 1978, 118: 863-875.
Wurtemberger G, Herceg R, Matthys H, Ferber E, Costabel U: [Surfactant phospholipids in bronchoalveolar lavage fluid in smokers with healthy lungs and non-smokers]. Pneumologie. 1990, 44 (Suppl 1): 310-311.
Hughes DA, Haslam PL: Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis. Eur Respir J. 1990, 3: 1128-1139.
Mancini NM, Bene MC, Gerard H, Chabot F, Faure G, Polu JM, Lesur O: Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Lung. 1993, 171: 277-291.
Zetterberg G, Curstedt T, Eklund A: A possible alteration of surfactant in broncho-alveolar lavage fluid from healthy smokers compared to non-smokers and patients with sarcoidosis. Sarcoidosis. 1995, 12: 46-50.
Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S: Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest. 1996, 109: 1006-1009.
Jimenez Ruiz CA, Rajas O, Ruiz A, Ramos A, Florez S, Ramos L, Solano S, Fornies E: Bronchoalveolar lavage in smokers: quantification of alveolar macrophages and neutrophils as markers of bronchial obstruction. In Vivo. 1998, 12: 427-430.
Warr GA, Martin RR: Histochemical staining and in vitro spreading of human pulmonary alveolar macrophages: variability with cigarette smoking status. J Reticuloendothel Soc. 1978, 23: 53-62.
Geiser M, Im Hof V, Siegenthaler W, Grunder R, Gehr P: Ultrastructure of the aqueous lining layer in hamster airways: is there a two-phase system?. Microsc Res Tech. 1997, 36: 428-437.
Konrad FX, Schreiber T, Brecht-Kraus D, Georgieff M: Bronchial mucus transport in chronic smokers and nonsmokers during general anesthesia. J Clin Anesth. 1993, 5: 375-380.
Basbaum C, Li D, Gensch E, Gallup M, Lemjabbar H: Mechanisms by which gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR). Novartis Found Symp. 2002, 248: 171-176. discussion 176–180, 277-182.
Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I, Ioli F, Chung KF, Donner CF, Barnes PJ, Adcock IM: Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J. 2002, 20: 556-563.
Cockshutt AM, Absolom DR, Possmayer F: The role of palmitic acid in pulmonary surfactant: enhancement of surface activity and prevention of inhibition by blood proteins. Biochim Biophys Acta. 1991, 1085: 248-256.
Lannan S, Donaldson K, Brown D, MacNee W: Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am J Physiol. 1994, 266: L92-100.
Rahman I, Li XY, Donaldson K, Harrison DJ, MacNee W: Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol. 1995, 269: L285-292.
Hoshino Y, Mio T, Nagai S, Miki H, Ito I, Izumi T: Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. Am J Physiol Lung Cell Mol Physiol. 2001, 281: L509-516.
D'Agostini F, Balansky RM, Izzotti A, Lubet RA, Kelloff GJ, De Flora S: Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis. 2001, 22: 375-380.
Spragg RG, Li J: Effect of phosphocholine cytidylyltransferase overexpression on phosphatidylcholine synthesis in alveolar type II cells and related cell lines. Am J Respir Cell Mol Biol. 2000, 22: 116-124.
Aoshiba K, Koinuma M, Yokohori N, Nagai A: Immunohistochemical evaluation of oxidative stress in murine lungs after cigarette smoke exposure. Inhal Toxicol. 2003, 15: 1029-1038.
Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, McCormack FX: Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem. 2000, 275: 38848-38855.
Kida K, Oda H, Yamano Y, Kagawa J: Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A). Eur Respir J. 1997, 10: 2124-2126.
Mohsenin V, Gee JB: Acute effect of nitrogen dioxide exposure on the functional activity of alpha-1-protease inhibitor in bronchoalveolar lavage fluid of normal subjects. Am Rev Respir Dis. 1987, 136: 646-650.
Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, Lewandoski J, Zimmerman JJ: Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis. Chest. 2000, 118: 164-174.
Enhorning G, Hohlfeld J, Krug N, Lema G, Welliver RC: Surfactant function affected by airway inflammation and cooling: possible impact on exercise-induced asthma. Eur Respir J. 2000, 15: 532-538.
Cheng G, Ueda T, Sugiyama K, Toda M, Fukuda T: Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma. Respir Med. 2001, 95: 180-186.
Jouanel P, Motta C, Brun J, Molina C, Dastugue B: Phospholipids and microviscosity study in broncho-alveolar lavage fluids from control subjects and from patients with extrinsic allergic alveolitis. Clin Chim Acta. 1981, 115: 211-221.
Kaup FJ, Drommer W, Damsch S, Deegen E: Ul-trastructural findings in horses with chronic obstructive pulmonary disease (COPD). II: Pathomorphological changes of the terminal airways and the alveolar region. Equine Vet J. 1990, 22: 349-355.
Lusuardi M, Capelli A, Carli S, Tacconi MT, Salmona M, Donner CF: Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration. 1992, 59 (Suppl 1): 28-32.
Wirtz HR, Schmidt M: Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur Respir J. 1996, 9: 24-32.
Muller B, von Wichert P: Effect of nitrogen dioxide inhalation on surfactant phosphatidylcholine synthesis in rat alveolar type II cells. Biochim Biophys Acta. 1993, 1170: 38-43.
Muller B, Seifart C, von Wichert P, Barth PJ: Adaptation of rat type II pneumocytes to NO2: effects of NO2 application mode on phosphatidylcholine metabolism. Am J Respir Cell Mol Biol. 1998, 18: 712-720.
Knight M, Sekharam M, Patel J: The effect of nitrogen dioxide exposure on the release of surfactant isolated from neonatal rabbit type II pneumocytes in culture. J Biochem Toxicol. 1995, 10: 309-313.
Wisborg K, Kesmodel U, Henriksen TB, Olsen SF, Secher NJ: Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol. 2001, 154: 322-327.
Stick SM, Burton PR, Gurrin L, Sly PD, LeSouef PN: Effects of maternal smoking during pregnancy and a family history of asthma on respiratory function in newborn infants. Lancet. 1996, 348: 1060-1064.
Wasowicz M, Zurawski P, Florek E, Senczuk W, Biczysko W: Retardation of lung development after maternal cigarette smoking and low protein diet in animal model. Pol J Pathol. 1994, 45: 155-162.
Gilliland FD, Berhane K, Li YF, Rappaport EB, Peters JM: Effects of Early Onset Asthma and In Utero Exposure to Maternal Smoking on Childhood Lung Function. Am J Respir Crit Care Med. 2002.
Hanrahan JP, Tager IB, Segal MR, Tosteson TD, Castile RG, Van Vunakis H, Weiss ST, Speizer FE: The effect of maternal smoking during pregnancy on early infant lung function. Am Rev Respir Dis. 1992, 145: 1129-1135.
Li YF, Gilliland FD, Berhane K, McConnell R, Gauderman WJ, Rappaport EB, Peters JM: Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med. 2000, 162: 2097-2104.
Young S, Le Souef PN, Geelhoed GC, Stick SM, Turner KJ, Landau LI: The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. N Engl J Med. 1991, 324: 1168-1173.
Segal MR, Wight S, Hanrahan JP, Tager IB: Maternal smoking during pregnancy and birth outcomes with weight gain adjustments via varying-coefficient models. Stat Med. 1997, 16: 1603-1616.
Cunningham J, Dockery DW, Speizer FE: Maternal smoking during pregnancy as a predictor of lung function in children. Am J Epidemiol. 1994, 139: 1139-1152.
Nelson E, Goubet-Wiemers C, Guo Y, Jodscheit K: Maternal passive smoking during pregnancy and foetal developmental toxicity. Part 2: histological changes. Hum Exp Toxicol. 1999, 18: 257-264.
Tager IB, Ngo L, Hanrahan JP: Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. Am J Respir Crit Care Med. 1995, 152: 977-983.
Hoo AF, Henschen M, Dezateux C, Costeloe K, Stocks J: Respiratory function among preterm infants whose mothers smoked during pregnancy. Am J Respir Crit Care Med. 1998, 158: 700-705.
Joad JP, Ji C, Kott KS, Bric JM, Pinkerton KE: In utero and postnatal effects of sidestream cigarette smoke exposure on lung function, hyperresponsiveness, and neuroendocrine cells in rats. Toxicol Appl Pharmacol. 1995, 132: 63-71.
Pastrakuljic A, Schwartz R, Simone C, Derewlany LO, Knie B, Koren G: Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci. 1998, 63: 2333-2342.
Luck W, Nau H, Hansen R, Steldinger R: Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther. 1985, 8: 384-395.
Szuts T, Olsson S, Lindquist NG, Ullberg S, Pilotti A, Enzell C: Long-term fate of [14C]nicotine in the mouse: retention in the bronchi, melanin-containing tissues and urinary bladder wall. Toxicology. 1978, 10: 207-220.
Iwatsuki H, Sasaki K, Suda M, Itano C: Cell differentiation of alveolar epithelium in the developing rat lung: ultrahistochemical studies of glyco-conjugates on the epithelial cell surface. Histo-chemistry. 1993, 100: 331-340.
Saetta M, Shiner RJ, Angus GE, Kim WD, Wang NS, King M, Ghezzo H, Cosio MG: Destructive index: a measurement of lung parenchymal destruction in smokers. Am Rev Respir Dis. 1985, 131: 764-769.
Jull BA, Plummer HK, Schuller HM: Nicotinic receptor-mediated activation by the tobacco-specific nitrosamine NNK of a Raf-1/MAP kinase pathway, resulting in phosphorylation of c-myc in human small cell lung carcinoma cells and pulmonary neuroendocrine cells. J Cancer Res Clin Oncol. 2001, 127: 707-717.
Lieberman E, Torday J, Barbieri R, Cohen A, Van Vunakis H, Weiss ST: Association of intrauterine cigarette smoke exposure with indices of fetal lung maturation. Obstet Gynecol. 1992, 79: 564-570.
Jagoe K, Edwards R, Mugusi F, Whiting D, Unwin N: Tobacco smoking in Tanzania, East Africa: population based smoking prevalence using expired alveolar carbon monoxide as a validation tool. Tob Control. 2002, 11: 210-214.
Polymorphisms and haplotypes of the chromosome locus 17q12-17q21.1 contribute to adult asthma susceptibility in Slovenian patients Mateja Žavbi, Peter Korošec, Matjaž Fležar, Sabina Škrgat Kristan, Mateja Marc Malovrh, Matija Rijavec Human Immunology
Enhanced phospholipase B activity and alteration of phospholipids and neutral lipids in Saccharomyces cerevisiae exposed to N-nitrosonornicotine Panneerselvam Vijayaraj, Jayaraja Sabarirajan, Vasanthi Nachiappan Antonie van Leeuwenhoek
In vitro exposure of tobacco specific nitrosamines decreases the rat lung phospholipids by enhanced phospholipase A2 activity Panneerselvam Vijayaraj, Chinnarasu Sivaprakasam, Lakshmanaperumal Vishnu Varthini, Mary Sarkar, Vasanthi Nachiappan Toxicology in Vitro
Cellular reactions to long-term volatile organic compound (VOC) exposures Johanna M. Gostner, Johannes Zeisler, Mohammad Tauqeer Alam, Peter Gruber, Dietmar Fuchs, Kathrin Becker, Kerstin Neubert, Markus Kleinhappl, Stefan Martini, Florian Überall Scientific Reports
Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers Maurizio Manigrasso, Giorgio Buonanno, Fernanda Carmen Fuoco, Luca Stabile, Pasquale Avino Environmental Pollution
Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation Virender K. Rehan, Ying Wang, Sharon Sugano, Sonia Romero, Xiaoru Chen, Jamie Santos, Aarti Khazanchi, John S. Torday American Journal of Physiology-Lung Cellular and Molecular Physiology
Eosinophil-Associated Lung Diseases. A Cry for Surfactant Proteins A and D Help? Julie G. Ledford, Kenneth J. Addison, Matthew W. Foster, Loretta G. Que American Journal of Respiratory Cell and Molecular Biology
Gestational Exposure to Sidestream (Secondhand) Cigarette Smoke Promotes Transgenerational Epigenetic Transmission of Exacerbated Allergic Asthma and Bronchopulmonary Dysplasia Shashi P. Singh, Hitendra S. Chand, Raymond J. Langley, Neerad Mishra, Ted Barrett, Karin Rudolph, Carmen Tellez, Piotr T. Filipczak, Steve Belinsky, Ali I. Saeed, Aryaz Sheybani, Vernat Exil, Hemant Agarwal, Venkataramana K. Sidhaye, Thomas Sussan, Shyam Biswal, Mohan Sopori The Journal of Immunology
The impact of cannabis smoke on the performance of pulmonary surfactant under physiologically relevant conditions Michael J. Davies, Jason W. Birkett, Olivia Court, Alicia Mottram, Farbod Zoroaster Surface and Interface Analysis
Surfactant phospholipid metabolism Marianna Agassandian, Rama K. Mallampalli Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Tandem mass tags labeled quantitative proteomics to study the effect of tobacco smoke exposure on the rat lung Shuangshuang Ma, Chunguo Wang, Baosheng Zhao, Xiaolei Ren, Simin Tian, Juan Wang, Chi Zhang, Yuanyang Shao, Minyi Qiu, Xueyong Wang Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD Charmion I. Cruickshank-Quinn, Sean Jacobson, Grant Hughes, Roger L. Powell, Irina Petrache, Katerina Kechris, Russell Bowler, Nichole Reisdorph Scientific Reports
Cigarillos Compromise the Mucosal Barrier and Protein Expression in Airway Epithelia Sabri Abdelwahab, Boris Reidel, Jessica Martin, Arunava Ghosh, James Keating, Prashamsha Haridass, Jerome Carpenter, Gary Glish, Robert Tarran, Claire Doerschuk, Mehmet Kesimer American Journal of Respiratory Cell and Molecular Biology
Betulinic acid abates
N
‐nitrosodimethylamine‐induced changes in lipid metabolism, oxidative stress, and inflammation in the liver and kidney of Wistar rats Gbadebo Adeleke, Oluwatosin Adaramoye Journal of Biochemical and Molecular Toxicology
Passive Vaping from Sub-Ohm Electronic Cigarette Devices Maurizio Manigrasso, Carmela Protano, Matteo Vitali, Pasquale Avino International Journal of Environmental Research and Public Health
Probing for factors influencing exhaled breath drug testing in sports— Pilot studies focusing on the tested individual's tobacco smoking habit and sex Ann‐Marie Garzinsky, Andreas Thomas, Mario Thevis Rapid Communications in Mass Spectrometry
Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques Chrysi Keskinidou, Alice Vassiliou, Ioanna Dimopoulou, Anastasia Kotanidou, Stylianos Orfanos Journal of Inflammation Research
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers Sang-Ryul Cha, Jimin Jang, Sung-Min Park, Se Ryu, Seong-Joon Cho, Se-Ran Yang Antioxidants
Deciphering the bioactive compounds for the expectorant effect of FF based on the gut and lung metabolomics Xianlong Dong, Zhe Kong, Linxu Cao, Xuemei Qin, Zhenyu Li
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.